Mr. Bauman has over ten years of global medical device experience focused on development, regulatory, reimbursement, and commercialization strategies for new cardiovascular, orthopedic, and spine products. This includes several successful US FDA regulatory submissions (510(k)’s, IDE’s, PMA’s) and EU filings (Technical Files, Design Dossiers), successful international clinical trial operations management and execution, and securing favorable reimbursement status for new medical technologies at the national coverage level. Mr. Bauman earned a BS in chemistry from Emory University and a BS in biomedical engineering from the Georgia Institute of Technology and a MS in regulatory science from Johns Hopkins University.